Bio-Rad Intends to Propose Three New Independent Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Bio-Rad Labs (BIO) PT Raised to $250 at Jefferies; Sees Path to $300
March 14, 2017 6:37 AM EDTJefferies raised its price target on Bio-Rad Labs (NYSE: BIO) to $250.00 (from $225.00) while maintaining a Buy rating. The analyst also sees a path to $300 share.
Analyst Brandon Couillard commented, "Time to forget everything you thought you knew about BIO -- as two separate... More



